Lotus Pharmaceutical Co Ltd (美時化學製藥) yesterday reported that second-quarter profit was NT$298 million (US$10.1 million), 4.75 times what it was a year earlier, due to strong revenue performance by an anti-obesity drug and a treatment for opiate addiction.
Earnings per share were NT$1.23, the highest in a single quarter, a company statement said.
Consolidated revenue gained 41.3 percent annually to NT$2.67 billion in the April-to-June period, despite challenging market conditions amid the COVID-19 pandemic and unfavorable foreign exchange rates, the statement said.
Revenue at the company’s South Korean unit grew 1.6 percent annually, thanks to rapid growth in sales of its anti-obesity drug Qsymia, even though the New Taiwan dollar appreciated against the won, Lotus Pharmaceutical said.
Cumulative sales of Qsymia, an oral medicine, as of the end of June surpassed 10 billion won (US$8.44 million) following its launch in November last year, Lotus Pharmaceutical spokeswoman Angela Luan (欒君儀) told the Taipei Times by telephone.
The drug is second in the anti-obesity drug market in South Korea, with a market share of 15.6 percent as of the end of June, following Novo Nordisk A/S’ Saxenda, which has a market share of 24.8 percent, Luan said.
Revenue from ASEAN markets, including Thailand and Vietnam, rose 4 percent year-on-year in the second quarter, boosting its total revenue in Asia by 11.6 percent to NT$1.6 billion, the company said.
Revenue from markets outside Asia rose 161.7 percent year-on-year to NT$1.01 billion, on the back of strong sales of narcotic addiction treatment gSuboxone, it said.
Due to lower prices for gSuboxone, a generic version of Indivior Inc’s Suboxone, Lotus Pharmaceutical’s drug has been included in the public health program and private health insurance programs in the US, lifting its market share to 35 percent as of the second quarter, it said.
The company maintained its forecast of high single-digit percentage growth in overall revenue this year, Luan said.
However, gross margin fell to 40.2 percent in the second quarter from 50.9 percent a year earlier, as it generated more sales from gSuboxone with margin of 30 to 40 percent, it said.
Research and development expenses declined 31.2 percent annually to NT$86 million last quarter, as some of its research projects were postponed or affected by lockdowns around the world amid the pandemic, Luan said.
TARIFF TRADE-OFF: Machinery exports to China dropped after Beijing ended its tariff reductions in June, while potential new tariffs fueled ‘front-loaded’ orders to the US The nation’s machinery exports to the US amounted to US$7.19 billion last year, surpassing the US$6.86 billion to China to become the largest export destination for the local machinery industry, the Taiwan Association of Machinery Industry (TAMI, 台灣機械公會) said in a report on Jan. 10. It came as some manufacturers brought forward or “front-loaded” US-bound shipments as required by customers ahead of potential tariffs imposed by the new US administration, the association said. During his campaign, US president-elect Donald Trump threatened tariffs of as high as 60 percent on Chinese goods and 10 percent to 20 percent on imports from other countries.
Taiwanese manufacturers have a chance to play a key role in the humanoid robot supply chain, Tongtai Machine and Tool Co (東台精機) chairman Yen Jui-hsiung (嚴瑞雄) said yesterday. That is because Taiwanese companies are capable of making key parts needed for humanoid robots to move, such as harmonic drives and planetary gearboxes, Yen said. This ability to produce these key elements could help Taiwanese manufacturers “become part of the US supply chain,” he added. Yen made the remarks a day after Nvidia Corp cofounder and chief executive officer Jensen Huang (黃仁勳) said his company and Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) are jointly
United Microelectronics Corp (UMC, 聯電) expects its addressable market to grow by a low single-digit percentage this year, lower than the overall foundry industry’s 15 percent expansion and the global semiconductor industry’s 10 percent growth, the contract chipmaker said yesterday after reporting the worst profit in four-and-a-half years in the fourth quarter of last year. Growth would be fueled by demand for artificial intelligence (AI) servers, a moderate recovery in consumer electronics and an increase in semiconductor content, UMC said. “UMC’s goal is to outgrow our addressable market while maintaining our structural profitability,” UMC copresident Jason Wang (王石) told an online earnings
MARKET SHIFTS: Exports to the US soared more than 120 percent to almost one quarter, while ASEAN has steadily increased to 18.5 percent on rising tech sales The proportion of Taiwan’s exports directed to China, including Hong Kong, declined by more than 12 percentage points last year compared with its peak in 2020, the Ministry of Finance said on Thursday last week. The decrease reflects the ongoing restructuring of global supply chains, driven by escalating trade tensions between Beijing and Washington. Data compiled by the ministry showed China and Hong Kong accounted for 31.7 percent of Taiwan’s total outbound sales last year, a drop of 12.2 percentage points from a high of 43.9 percent in 2020. In addition to increasing trade conflicts between China and the US, the ministry said
RSS